Exodus Point Capital Management, LP Cyma Bay Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$10.86 - $17.62 $148,032 - $240,178	13,631 New	13,631 $203,000
Q3 2022 Nov 10, 2022	SELL	$2.77 - $4.25 $37,491 - $57,523	-13,535 Closed	0 $0
Q2 2022 Aug 19, 2022	SELL	$1.72 - $3.39 $45,906 - $90,479	-26,690 Reduced 66.35%	13,535 $40,000
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $13,102 - $17,217	4,730 Added 13.33%	40,225 $125,000
Q4 2021 Feb 11, 2022	BUY	$3.23 - $4.6 $114,648 - $163,277	35,495 New	35,495 $120,000
Q3 2021 Nov 15, 2021	SELL	$3.47 - $4.42 $99,654 - $126,937	-28,719 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.94 - $4.92 $43,261 - $54,021	10,980 Added 61.9%	28,719 $125,000
Q1 2021 May 17, 2021	BUY	$4.23 - $6.55 $75,035 - $116,190	17,739 New	17,739 $81,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $114,433 - $180,338	-19,971 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.32 - $7.24 $239,109 - $521,432	-72,021 Reduced 78.29%	19,971 $145,000
Q2 2020 Aug 14, 2020	BUY	$1.41 - $4.25 $129,708 - $390,966	91,992 New	91,992 $321,000
Q3 2019 Nov 14, 2019	SELL	$5.12 - $7.21 $92,887 - $130,803	-18,142 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.05 - $13.66 $216,959 - $489,861	-35,861 Reduced 66.41%	18,142 $130,000
Q1 2019 May 15, 2019	BUY	$8.16 - $13.42 $440,664 - $724,720	54,003 New	54,003 $717,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.